All-In with Chamath, Jason, Sacks & FriedbergOpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

Retatrutide’s Triple-Receptor Edge

59:09–1:00:23 · 74s

Friedberg breaks down why Lilly’s next-gen drug could be a game-changer for fat loss and metabolic markers, with striking early results.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.